HempFusion
Wellness Enters China with
Probulin Probiotics Through
Alibaba Group's T-Mall Global, Reaching More Than 750
Million Potential
New
Consumers
DENVER, CO
-- March 18, 2021 -- InvestorsHub NewsWire
-- HempFusion Wellness
Inc. (TSX:CBD.U) (US:CBDHF) (FWB:8OO) ("HempFusion" or the
"Company"), a leading health and wellness company offering premium
probiotic supplements and products containing CBD, is pleased to
announce the launch of certain products through its
wholly-owned subsidiary, Probulin
Probiotics, LLC ("Probulin"), on Alibaba Group
Holding's Tmall Global ("Tmall"), the
world's largest cross border online
marketplace reaching more than 750
million
consumers in mainland China, Hong Kong, Macau and
Taiwan.
"This
strategic launch provides us with a tremendous opportunity to reach
one of the largest online consumer bases in the world and drive
significant revenue for the Company," said Jon Visser, HempFusion's
Chief Revenue Officer.
With shipments expected to
begin early next week, HempFusion expects
its
Probulin
products
to be available
for purchase on Tmall with a go live date currently
set at March 29, 2021, ahead of one of China's
largest single day shopping extravaganzas, the
mid-year
618 shopping festival, which shattered records last year with
more than USD$98.52 billion in
single day
sales.
The Probulin products expected to be made
available
online through Tmall
in
greater
China will
include
Total Care Immune,
Total Care,
Daily
Care,
Women's Health,
Colon Support and
My Little Bugs™ Total
Care Probiotic For Kids.
Tmall
regularly engages consumers with brands through livestreaming,
educational videos and group chats. "Probulin
looks
forward to utilizing our growing team of celebrity influencers
to take
advantage
of these innovative, interactive opportunities to reach new
consumers in a fun and entertaining way.
Additionally, we
look forward to launching more of our brands in
China
through Tmall in the near future,"
continued Mr.
Visser.
In
2020,
health
supplements and probiotics were among the
most popular categories on the Tmall platform.
"Launching in China is a
tremendous milestone and an unparalleled opportunity to educate the
enormous Chinese market on the many health benefits of
probiotics," stated Dr. Jason Mitchell, N.D.,
HempFusion's
Co-Founder and
CEO. "At Probulin, we stand on integrity, offering only the
highest quality products and radical transparency throughout the
entire process."
"We believe Probulin
to be
the first
American company to deliver cold and protected probiotic
supplements direct to Chinese consumers," continued Dr. Mitchell.
"In
addition, our scientifically validated MAKTrek?
3-D Probiotic
Delivery System is designed to protect and nourish the
probiotics
so that more can arrive alive in the gut. These two distinguishing
factors result in a positive influence on the microbiome and
overall wellness."
Recognized as one of the
fastest-growing probiotics brands in the United States
by SPINs
syndicated
data, HempFusion's
Probulin products
are available in eight countries around the world and represent the
next generation of probiotics for digestive health and immune
support based entirely on cultured food and scientifically studied
strains.
ABOUT
HEMPFUSION
HempFusion is a
leading health and wellness CBD company utilizing the power of
whole-food hemp nutrition. HempFusion distributes its family of
brands, including HempFusion, Probulin Probiotics, Biome Research,
and HF Labs, to approximately 4,000 retail locations across
all 50 states of the United States and select international
locations. Built on a foundation of regulatory compliance and human
safety, HempFusion's diverse product portfolio comprises 48 SKUs
including tinctures, proprietary FDA Drug Listed
Over-The-Counter (OTC) Topicals, Doctor/Practitioner Lines and
more. With a strong focus on research and development, HempFusion
has an additional 30 products under development. HempFusion is a
board member of the US Hemp Roundtable, and HempFusion's wholly-owned
subsidiary, Probulin Probiotics, is one of the fastest-growing
probiotics companies in the United States, according to SPINs
reported data. HempFusion's CBD products are based on a proprietary
Whole Food Hemp Complex™ and are available in-store or by visiting
HempFusion online at www.hempfusion.com or www.probulin.com.
Follow HempFusion
on Twitter,
Facebook
and
Instagram
and
Probulin
on Twitter,
Facebook
and
Instagram.
CONTACT
INFORMATION
Jason Mitchell,
N.D.
Chief Executive Officer
and Director
Email: ir@hempfusion.com
Phone:
416-803-5638
FORWARD-LOOKING
STATEMENTS
This news release contains
forward-looking statements and forward-looking information within
the meaning of Canadian securities legislation (collectively,
"forward-looking
statements") that relate to
HempFusion's current expectations and views of future events. Any
statements that express, or involve discussions as to,
expectations, beliefs, plans, objectives, assumptions or future
events or
performance (often, but not always, through the use of words or
phrases such as "will likely result", "are expected to", "expects",
"will continue", "is anticipated", "anticipates", "believes",
"estimated", "intends", "plans", "forecast",
"projection", "strategy", "objective" and
"outlook") are not historical facts and may be forward-looking
statements and may involve estimates, assumptions and uncertainties
which could cause actual results or outcomes to differ materially
from those expressed in such forward-looking statements.
No assurance can be given that these expectations will prove to be
correct and such forward-looking statements included in this news
release should not be unduly relied upon. These statements speak
only as of the date of this news release. In particular and
without limitation, this news release contains forward-looking
statements relating to the launch of the Company's
Probulin products on Tmall and the timing and revenue
opportunity thereof, planned launch of
the Company's additional brands in China
and the Company's
other plans, focus and objectives.
Forward-looking statements
are based on a number of assumptions and are subject to a number of
risks and uncertainties, many of which are beyond HempFusion's
control, which could cause actual results and events
to differ materially from those that are disclosed in or implied by
such forward-looking statements. Such risks and uncertainties
include, but are not limited to, the impact and progression of the
COVID-19 pandemic and other factors set forth under
"Forward-Looking
Statements" and "Risk
Factors"
in the final long form prospectus of the Company dated December 17,
2020 and available under the Company's profile on SEDAR at
www.sedar.com. HempFusion undertakes no obligation to update or
revise any forward-looking statements, whether as a result of
new
information, future events or otherwise, except as may be required
by law. New factors emerge from time to time, and it is not
possible for HempFusion to predict all of them or assess the impact
of each such factor or the extent to which any factor, or
combination of
factors, may cause results to differ materially from those
contained in any forward-looking statement. Any forward-looking
statements contained in this news release are expressly qualified
in their entirety by this cautionary statement.
Neither
the TSX nor its Regulation Services Provider (as that term is
defined in the policies of the TSX) accepts responsibility for the
adequacy or accuracy of this release.
